Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$71,959,750
+$23,415,300 QoQ
Shares Held
1,309,788
-10.4% QoQ
Ownership
0.856%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$3,726,000
PutShares
150,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. TGTX ranks #34 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TGTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,959,750 | 1,309,788 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $48,544,450 | 1,461,302 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $25,371,497 | 851,107 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $22,637,835 | 626,653 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $20,419,931 | 567,378 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,988,885 | 684,476 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,951,261 | 230,939 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $39,701,530 | 1,697,372 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $37,036,786 | 2,081,888 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $33,484,053 | 2,201,450 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,959,142 | 583,088 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,402,431 | 646,224 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,806,613 | 314,276 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $3,726,000 | 150,000 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $10,987,109 | 730,526 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,612,100 | 897,050 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,763,899 | 973,632 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,449,281 | 811,596 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,564,009 | 900,527 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,077,559 | 635,661 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $14,695,680 | 441,577 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,784,481 | 484,261 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $37,500,610 | 778,021 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $19,923,346 | 382,994 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $4,159,065 | 155,421 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,364,050 | 121,358 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,055,308 | 107,247 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||